title: Medication overuse headache: a silent pandemic.
authors.affiliation: Department of Neurology, Northampton General Hospital, NHS Trust, Billing Rd., Northampton, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Davies
mesh_terms: D000700:Analgesics / Q000009:adverse effects*; D005260:Female; D051271:Headache Disorders, Secondary / Q000453:epidemiology*; D006801:Humans; D008297:Male
chemical_list: D000700:Analgesics
references.citation: Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet neurol. 2004;3:475-483.
references.citation: Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010;9:391-401.
references.citation: Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart J-A. Risk factors for medication-overuse headache: An 11 year follow up. The Nord-Trøndelag Health Studies. Pain. 2011;153:56-61.
references.citation: Headache Classification Committee, Olesen J, Bousser MG, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742-746.
references.citation: Limmroth V, Kazarawa S, Fritsche G, Przywara S, Diener H-C. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002;59:1011-1014.
references.citation: Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc. 1951;26:153-161.
references.citation: Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48:16-25.
references.citation: The International Classification of Headache Disorders: 2nd edition. Headache Classification Subcommittee of the International Headache Society. Cephalalgia 2004;24:9-160.